SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Andrew Eisenberger, Carolyn Westhoff, Hormone replacement therapy and venous thromboembolism, The Journal of Steroid Biochemistry and Molecular Biology, 2014, 142, 76

    CrossRef

  2. 2
    Natalie M. Trotter, Amanda A. Wheeler, Bilateral Pulmonary Emboli: A Case Review, Athletic Training & Sports Health Care, 2013,

    CrossRef

  3. 3
    &NA;, Committee Opinion No. 556, Obstetrics & Gynecology, 2013, 121, 4, 887

    CrossRef

  4. 4
    R. E. J. ROACH, W. M. LIJFERING, F. M. HELMERHORST, S. C. CANNEGIETER, F. R. ROSENDAAL, A. van HYLCKAMA VLIEG, The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy, Journal of Thrombosis and Haemostasis, 2013, 11, 1
  5. 5
    Manish Mehta, MD Paty, MD Byrne, MD Sternbach, MD Taggert, Kathleen Ozsvath, The Clinical Nanomedicine Handbook, 2013,

    CrossRef

  6. 6
    D. F. Archer, E. Oger, Estrogen and progestogen effect on venous thromboembolism in menopausal women, Climacteric, 2012, 15, 3, 235

    CrossRef

  7. 7
    S. SWEETLAND, V. BERAL, A. BALKWILL, B. LIU, V. S. BENSON, M. CANONICO, J. GREEN, G. K. REEVES, Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study, Journal of Thrombosis and Haemostasis, 2012, 10, 11
  8. 8
    Lidija Tasic, Radica Dunjic, Mladenko Vasiljevic, Svetlana Dikic, Aleksandar Jurisic, Dijana Tasic, Comparison of two different types of hormone therapy effects on haemostatic parameters in early postmenopausal women, Srpski arhiv za celokupno lekarstvo, 2011, 139, 1-2, 52

    CrossRef

  9. 9
    A. VAN HYLCKAMA VLIEG, S. MIDDELDORP, Hormone therapies and venous thromboembolism: where are we now?, Journal of Thrombosis and Haemostasis, 2011, 9, 2
  10. 10
    Valérie Olié, Marianne Canonico, Pierre-Yves Scarabin, Postmenopausal hormone therapy and venous thromboembolism, Thrombosis Research, 2011, 127, S26

    CrossRef

  11. 11
    Bryce Williams, A. Thomas Indresano, Felice O'Ryan, Venous Thromboembolism in Oral and Maxillofacial Surgery: A Review of the Literature, Journal of Oral and Maxillofacial Surgery, 2011, 69, 3, 840

    CrossRef

  12. 12
    Michel K. Barsoum, John A. Heit, Aneel A. Ashrani, Cynthia L. Leibson, Tanya M. Petterson, Kent R. Bailey, Is progestin an independent risk factor for incident venous thromboembolism? A population-based case-control study, Thrombosis Research, 2010, 126, 5, 373

    CrossRef

  13. 13
    Joanna Ueng, James D. Douketis, Prevention and Treatment of Hormone-Associated Venous Thromboembolism: A Patient Management Approach, Hematology/Oncology Clinics of North America, 2010, 24, 4, 683

    CrossRef

  14. 14
    Valérie Olié, Marianne Canonico, Pierre-Yves Scarabin, Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women, Current Opinion in Hematology, 2010, 17, 5, 457

    CrossRef

  15. 15
    Saskia Middeldorp, Epidemiology of hormone-related venous thromboembolism, Thrombosis Research, 2009, 123, S65

    CrossRef

  16. 16
    BARBARA BINDER, HELMUT KARL LACKNER, WOLFGANG SALMHOFER, RAINER HOFMANN-WELLENHOF, Risk Factors for Deep Vein Thrombosis in Women Aged 18 to 50: A Retrospective Analysis, Dermatologic Surgery, 2009, 35, 3
  17. 17
    Stephen W. Littleton, Babak Mokhlesi, The Pickwickian Syndrome—Obesity Hypoventilation Syndrome, Clinics in Chest Medicine, 2009, 30, 3, 467

    CrossRef

  18. 18
    Marc L’Hermite, Tommaso Simoncini, Sarah Fuller, Andrea Riccardo Genazzani, Could transdermal estradiol+progesterone be a safer postmenopausal HRT? A review, Maturitas, 2008, 60, 3-4, 185

    CrossRef

  19. 19
    Emmanuel Oger, Karine Lacut, Bernard Mercier, Grégoire Le Gal, Christophe Leroyer, Elisabeth Pasquier, Claude Férec, Dominique Mottier, Estrogen receptor alpha polymorphism and venous thromboembolism in male and female: Data from the EDITH study, Thrombosis Research, 2007, 119, 4, 433

    CrossRef

  20. 20
    Tullia Battaglioli, Ida Martinelli, Hormone therapy and thromboembolic disease, Current Opinion in Internal Medicine, 2007, 6, 6, 607

    CrossRef

  21. 21
    Sun Young Kim, Jong Hyeok Park, Hyun Kyung Lee, Hyuk Pyo Lee, Hye Kyung Lee, Soo Jeon Choi, Ho-Kee Yum, Pulmonary Thromboembolism after Post-menopause Hormonal Replacement Therapy, Tuberculosis and Respiratory Diseases, 2007, 63, 4, 362

    CrossRef

  22. 22
    Henry G. Watson, Sex Hormones and Thrombosis, Seminars in Hematology, 2007, 44, 2, 98

    CrossRef

  23. 23
    Gordon DO Lowe, Update on the cardiovascular risks of hormone replacement therapy, Women's Health, 2007, 3, 1, 87

    CrossRef

  24. 24
    Carolyn Westhoff, Treatment of the Postmenopausal Woman, 2007,

    CrossRef

  25. 25
    A.L. Eilertsen, E. Qvigstad, T.O. Andersen, L. Sandvik, P.M. Sandset, Conventional-dose hormone therapy (HT) and tibolone, but not low-dose HT and raloxifene, increase markers of activated coagulation, Maturitas, 2006, 55, 3, 278

    CrossRef

  26. 26
    Nanette K. Wenger, Tratamiento hormonal sustitutivo y enfermedades cardiovasculares, Revista Española de Cardiología, 2006, 59, 10, 1058

    CrossRef

  27. 27
    Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions, 2006,

    CrossRef

  28. 28
    Current awareness: Pharmacoepidemiology and drug safety, Pharmacoepidemiology and Drug Safety, 2005, 14, 11
  29. 29
    Olivia Wu, Postmenopausal hormone replacement therapy and venous thromboembolism, Gender Medicine, 2005, 2, S18

    CrossRef